
A single batch of blood pressure pills is being pulled from pharmacy shelves nationwide after the manufacturer found it may contain metal pieces sharp enough to cut a patient from the inside.
Quick Take
- Breckenridge Pharmaceutical recalled one lot of Propranolol Hydrochloride Extended-Release Capsules, 60 mg, over possible metal contamination.
- The company warns the metal could cause cuts in the mouth, throat, stomach, or intestines.
- The affected lot, number PK25110035, shipped nationwide to wholesalers and pharmacies between October 26 and November 4, 2026.
- No injuries have been reported, and the company has not confirmed a metal fragment was actually found inside the recalled lot itself.
What Breckenridge Told the Public
Breckenridge Pharmaceutical announced a voluntary nationwide recall on November 16, 2026. The target is one lot of Propranolol Hydrochloride Extended-Release Capsules, a generic beta blocker doctors prescribe for high blood pressure and heart problems. The company says the pills might contain metal, and it wants every bottle from this lot off the market right away.
Patients and pharmacists can pin down exactly which bottles are affected. The recall covers 100-count bottles carrying NDC number 51991-817-01, lot number PK25110035, with an expiration date of May 2029. That precision matters. It means a pharmacist can check a bottle in seconds instead of guessing whether a customer’s prescription is part of the problem.
Why the Company Says Cuts Are Possible
Breckenridge did not mince words about the danger. The company stated that using capsules from the affected lot “could potentially cause lacerations of soft tissues in the oral cavity, esophagus, stomach, or intestine.” That means a tiny piece of metal swallowed with a capsule could slice tissue on its way through the digestive tract.
The company traced the scare to a shared ingredient. It said the recalled lot used intermediate material suspected to be the source of metal contamination already confirmed in a different lot. That second lot never made it to market, but the connection raised enough concern for Breckenridge to pull the related batch out of caution.
How Widely the Pills Already Traveled
The timing and reach of distribution explain why this recall touched so many states at once. Breckenridge shipped the lot to wholesalers and pharmacies across the country between October 26 and November 4, 2026. A ten-day shipping window spread the product through normal pharmacy supply chains before anyone flagged a contamination risk.
Patients taking the drug are being told to act, not panic. The recall instructs anyone with the affected lot to stop taking it and call their doctor or pharmacist for a replacement before discontinuing their blood pressure medicine on their own. Unused bottles should go back to the pharmacy where they were purchased, and distributors are checking their own inventory.
What Remains Unconfirmed So Far
Breckenridge has not reported any confirmed injuries connected to this lot as of its announcement. The company’s language describes a potential risk tied to shared manufacturing material, not a confirmed fragment pulled from a capsule in this specific batch.
Where This Recall Fits the Bigger Picture
Metal and particle contamination shows up in drug recalls more often than most people realize. Federal drug safety records list past recalls over glass particles, cellulose fibers, polymer bits, and stopper material turning up in injectable and oral medicines, sorted by how serious the health threat is judged to be. Manufacturing guidance for drug ingredients also tells companies to have a written plan for recalling an intermediate material the moment contamination is suspected anywhere in its supply chain, which is exactly the chain of reasoning Breckenridge described.
That broader pattern puts this recall in familiar territory for the pharmaceutical industry, even though the specific laceration risk makes it stand out. Oral medicine capsules rarely carry a stated risk of cutting internal organs, which is likely why this particular recall grabbed national attention despite covering just one lot.
💊 BLOOD PRESSURE MEDICATION RECALLED NATIONWIDE OVER POSSIBLE METAL CONTAMINATION
Breckenridge Pharmaceutical Inc. issued a voluntary nationwide recall for one lot of 60 mg propranolol hydrochloride extended-release capsules (lot PK25110035, expiring May 2029) over potential…
— Erik Hoffmann (@TheErikHoffmann) November 17, 2026
Patients on blood pressure medication should treat any recall notice seriously but calmly. Checking a bottle’s lot number takes thirty seconds and settles the question immediately. Stopping a heart medication without a doctor’s guidance carries its own risks, so the smarter move is calling the pharmacy first and swapping bottles before skipping doses altogether.
Sources:
washingtontimes.com, prnewswire.com, kmbc.com, kbtx.com, houstonchronicle.com, ksn.com, fda.gov
© standardnewsdaily.com 2026. All rights reserved.













